Media Room
- DBV Technologies Expands Scientific Advisory Board with Appointment of Leading Paediatric Allergy Specialist.
18 December 2009 - DBV Technologies Expands Scientific Advisory Board with Appointment of Leading Food and Paediatric Allergy Specialists.
19 October 2009 - DBV Technologies and BIOPROJET Enter Into Distribution Agreement For Diallertest® Milk.
12 October 2009 - DBV Technologies expands board of directors.
19 February 2009 - DBV Technologies raises €6 million (EUR) in Series B investment and secures new corporate investor.
22 January 2009 - DBV Technologies stengthens board of directors and scientific advisory board.
24 November 2007 - DBV Technologies expands management team and moves to new facilities in Paris.
17 November 2007 - DBV Technologies and Numico (€2.6 billion of revenues in 2006) enter into an exclusive distribution agreement.
13 November 2007 - Sofinnova and Apax Partners invest €12 million in DBV Technologies.
1 January 2006
Events
DBV Technologies will have a presence at a number of events:
- World Allergy Congress: http://worldallergy.org
In the press
General public
Trade Press
- Product focus: The E-patch. Scrip Drug Delivery.
November 2006
Scientific Press
- A pilot study of the usefulness and safety of a ready-to-use atopy patch test (Diallertest®) versus a comparator (Finn Chamber) during cow’s milk allergy in children. The Journal of Allergy and Clinical Immunology.
December 2005 (Vol. 116, Issue 6, Pages 1321-1326)
